Dustin Tetzl

Dustin Tetzl, MD, serves as the Chief Business Officer at Terran Biosciences since August 2019. Previously, Tetzl co-founded Enzyvant, where responsibilities included Business Development and Medical Affairs until its acquisition by Sumitomo Dainippon in August 2019. Tetzl was also part of the founding team at Roivant Sciences, focusing on Business Development from May 2014 to August 2019, during which the company was listed on Nasdaq under the ticker ROIV. Earlier experience includes a role as Senior Medical Consultant at Med School Tutors, acquired by Blueprint, and positions as a Neuroimaging Research Associate at NYU Langone Medical Center and Neuroscience Research Associate at Keck Medicine of USC. Tetzl earned a Doctor of Medicine (M.D.) from Columbia University Vagelos College of Physicians and Surgeons and a B.A. in Biological Sciences and Neuroscience from the University of Southern California.